Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ -7hU1j~I
hekAics6S
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© pNCk~OM
_hK7hvM>
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© )
^!oM
e*:[#LJ]C
1.Co-stimulators (or co-stimulating molecules) 5d
<-y2!M
t-3wjS1v
2.NK-kB t?
yMuK
&7XB$
3.Immunoglobulin superfamily (<=qW_iW
"u3
4.antigen-presenting cell (APC) p$0;~1vH
VABrw
t
5.death domain N|WnUlf]:
Yono8M;9*
6.CCR and CXCR oy;N3
>OBuHqC
7.Lectin (or mitogen) k'xnl"q
eN,s#/ip]
8.Clusters of differentiation, CD) _C)u#]t
?A8Uf=
9.B7 family `Btdp:j8i
o`DBzC
10.Cytotoxic T lymphocyte, CTL) H2zd@l:R
BO#fzq%
11.IL-15 and IL-15 receptor (IL-15R) KJ.ra\
F
SrN0f0
12.MHC restriction XaR(q2s
]zhFFq`
13.Affinity-chromatography _U.8
\J2
&dbX>u q
14.Cyctosprin A, CsA V}'|a<8kVv
hh |'Uq3
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) <*3wnpj_
?$ Uk[
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© *[.+|v;A
1 mFc]1W
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 IE|x+RBD
6:330"9
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ XFG]%y=/6
w^A8ZT0^7
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
nUs)
R+]Fh4t
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© ~
W52Mbf
K)_0ej~C
ÃâÒßѧרҵ£º eq(|%]a=
r1}7Q7-z
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ : b $
M
:2 QA
#
Ïû»¯ÄÚ¿Æ£º j9y,UT
ZH0 ~:
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ nITr5$f
+\"@2mOH{+
ѪҺ²¡Ñ§×¨Òµ£º Z TjlGU `
a9FlzR
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿